CataRhex 3® - Strong, Beautiful, Unique – For You

Article

CataRhex 3 ? Phaco without Limits Never before has cutting-edge technology for anterior segment surgery been as easily and reliably available, and never before has its packaging been more compact and tempting.

CataRhex 3® - Strong, Beautiful, Unique – For You

Weighing as little as 5 kg and fitting in any pilot case, CataRhex 3® can be mounted on any IV pole with a click – it is thus the epitome of portable equipment. A device that takes up so little space and is so easy to handle is becoming increasingly attractive in both outpatient and high-volume clinics. After all, CataRhex3® offers the latest phaco technology, from clear lens exchange to the hardest lenses. CataRhex 3 easyPhaco® Technology is available for 1.6, 2.2 and 2.8mm incisions with unparalleled efficiency and chamber stability. The newly developed CortexModeTM makes I/A with capsule cleaning noticeably safer and faster. Anterior vitrectomies can be precisely controlled with the high-precision flow control and the pneumatic Twinac cutting instrument and thanks to the integrated air pressure compressor they are available at all times.

CataRhex 3® is a trend-setter: the HFDS® ab interno function provides MIGS technology which elegantly enables combined glaucoma/phaco surgery. In terms of femto LRCS, too, CataRhex 3® excels with perfect fragment aspiration.

Contact details:
Fabienne Kast, Product Manager Anterior
fabienne.kast@oertli-instruments.comwww.oertli-catarhex3.com

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.